14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.98 $159.34 Friday, 3rd May 2024 ALNY stock ended at $152.33. This is 1.34% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 2.30% from a day low at $151.91 to a day high of $155.41.
90 days $141.98 $173.18
52 weeks $141.98 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Mar 30, 2023 $196.47 $197.92 $190.85 $195.12 587 473
Mar 29, 2023 $188.61 $196.23 $188.14 $195.91 806 829
Mar 28, 2023 $190.51 $194.25 $187.94 $188.55 1 304 918
Mar 27, 2023 $191.02 $191.81 $188.00 $190.51 938 366
Mar 24, 2023 $190.25 $190.40 $185.89 $189.98 351 463
Mar 23, 2023 $192.54 $195.16 $189.11 $190.49 458 536
Mar 22, 2023 $190.46 $194.76 $187.40 $189.74 1 237 136
Mar 21, 2023 $189.35 $191.06 $187.81 $190.43 958 575
Mar 20, 2023 $185.07 $188.25 $182.30 $187.52 560 163
Mar 17, 2023 $187.30 $189.14 $184.07 $185.45 883 353
Mar 16, 2023 $184.96 $190.09 $180.78 $189.66 870 029
Mar 15, 2023 $186.51 $187.98 $183.22 $185.75 622 331
Mar 14, 2023 $186.98 $189.69 $185.39 $187.10 1 120 962
Mar 13, 2023 $183.90 $189.99 $183.08 $184.86 1 353 484
Mar 10, 2023 $185.42 $185.96 $179.19 $182.66 980 618
Mar 09, 2023 $189.28 $191.85 $184.16 $185.95 1 099 290
Mar 08, 2023 $193.74 $195.07 $189.25 $190.41 547 132
Mar 07, 2023 $201.66 $201.66 $194.27 $194.34 593 182
Mar 06, 2023 $202.00 $203.89 $198.80 $199.70 446 006
Mar 03, 2023 $193.64 $205.14 $190.96 $202.58 951 041
Mar 02, 2023 $194.67 $195.70 $192.40 $194.44 545 974
Mar 01, 2023 $191.45 $196.85 $190.95 $195.40 675 596
Feb 28, 2023 $188.77 $191.94 $187.79 $191.45 1 205 823
Feb 27, 2023 $191.85 $193.19 $187.52 $190.01 710 890
Feb 24, 2023 $191.77 $199.58 $188.68 $189.78 1 521 273
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT